tradingkey.logo
tradingkey.logo
Search

Rapid Micro Biosystems Inc

RPID
Add to Watchlist
2.070USD
-0.250-10.78%
Close 05/15, 16:00ETQuotes delayed by 15 min
92.28MMarket Cap
LossP/E TTM

Rapid Micro Biosystems Inc

2.070
-0.250-10.78%

More Details of Rapid Micro Biosystems Inc Company

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Rapid Micro Biosystems Inc Info

Ticker SymbolRPID
Company nameRapid Micro Biosystems Inc
IPO dateJul 15, 2021
CEOSpignesi (Robert)
Number of employees163
Security typeOrdinary Share
Fiscal year-endJul 15
Address25 Hartwell Avenue
CityLEXINGTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code02421
Phone19783493200
Websitehttps://www.rapidmicrobio.com/
Ticker SymbolRPID
IPO dateJul 15, 2021
CEOSpignesi (Robert)

Company Executives of Rapid Micro Biosystems Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+12.88%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+37.05%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
29.44K
+2.86%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+12.88%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+37.05%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
29.44K
+2.86%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product revenue
23.43M
69.75%
Service revenue
10.16M
30.25%
By RegionUSD
Name
Revenue
Proportion
United States
13.43M
39.99%
Switzerland
6.02M
17.92%
All other countries
5.77M
17.18%
Germany
5.77M
17.17%
Japan
2.60M
7.73%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product revenue
23.43M
69.75%
Service revenue
10.16M
30.25%

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Bain Capital Life Sciences Investors, LLC
20.44%
Kennedy Lewis Investment Management LLC
11.97%
Longitude Capital Management Co., LLC
8.62%
Endeavour Medtech Growth II LP
5.47%
Ally Bridge Group (HK) Limited
4.48%
Other
49.02%
Shareholders
Shareholders
Proportion
Bain Capital Life Sciences Investors, LLC
20.44%
Kennedy Lewis Investment Management LLC
11.97%
Longitude Capital Management Co., LLC
8.62%
Endeavour Medtech Growth II LP
5.47%
Ally Bridge Group (HK) Limited
4.48%
Other
49.02%
Shareholder Types
Shareholders
Proportion
Investment Advisor
37.20%
Venture Capital
9.88%
Investment Advisor/Hedge Fund
6.28%
Corporation
5.47%
Individual Investor
4.45%
Hedge Fund
3.07%
Private Equity
1.40%
Research Firm
0.54%
Pension Fund
0.06%
Other
31.65%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
67
25.08M
60.78%
+607.83K
2025Q4
59
23.36M
58.78%
-1.87M
2025Q3
56
23.72M
59.74%
-1.53M
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Bain Capital Life Sciences Investors, LLC
8.43M
20.59%
--
--
Dec 31, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.06%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
4.08M
9.96%
-55.00K
-1.33%
Feb 03, 2026
Endeavour Medtech Growth II LP
2.26M
5.51%
--
--
Dec 31, 2025
Ally Bridge Group (HK) Limited
1.85M
4.51%
--
--
Dec 31, 2025
Spignesi (Robert G JR)
693.23K
1.69%
-17.92K
-2.52%
Mar 10, 2026
Advent International L.P.
577.78K
1.41%
--
--
Dec 31, 2025
Evernest Financial Advisors, LLC
125.00K
0.31%
-75.23K
-37.57%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proportion0.02%
Dimensional US Core Equity 1 ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI